Day 2 Program

Educational Session 9: Targeted Protein Degradation: Novel Approaches and Initial Clinical Steps

Day 2: December 9, 2026

2:30 PM–4:15 PM CST

Hemisfair 3

Session Details

Moderator

Qing Zhang, UT Southwestern Medical Center, Dallas, TX

ED9-02

Biologic Implications of Degraders Compared to Inhibitors

Wang Shaomeng

ED9-03

Lessons from the First PROTAC used in Cancer

Erika Hamilton, Sarah Cannon Research Institute, Nashville, TN